Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Cash from Operations (2022 - 2025)

Stoke Therapeutics has reported Cash from Operations over the past 4 years, most recently at 30454000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 31.31% year-over-year to 30454000.0; the TTM value through Dec 2025 reached 45585000.0, up 152.49%, while the annual FY2025 figure was 45585000.0, 152.49% up from the prior year.
  • Cash from Operations for Q4 2025 was 30454000.0 at Stoke Therapeutics, roughly flat from 30366000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 131827000.0 in Q1 2025 and troughed at 30454000.0 in Q4 2025.
  • A 4-year average of 9637437.5 and a median of 21707500.0 in 2023 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: crashed 165.73% in 2023 and later surged 636.62% in 2025.
  • Year by year, Cash from Operations stood at 22373000.0 in 2022, then grew by 7.71% to 20649000.0 in 2023, then decreased by 12.32% to 23193000.0 in 2024, then tumbled by 31.31% to 30454000.0 in 2025.
  • Business Quant data shows Cash from Operations for STOK at 30454000.0 in Q4 2025, 30366000.0 in Q3 2025, and 25422000.0 in Q2 2025.